Church & Dwight Company, Inc. (CHD) Stock Price & How to Invest
Last updated July 2026
Short answer
Church & Dwight (CHD) is a defensive large-cap consumer staples company behind Arm & Hammer, OxiClean, Trojan and a growing set of higher-growth personal-care brands, and investors typically treat it as a steady compounder that trades at a premium multiple. It appeals to people who want household-products exposure with a long dividend record, though the valuation leaves little room for execution slips.
CHD stock price
As of 2026-07-24, Church & Dwight Company, Inc. (CHD) last closed at $97.64, up 0.4% over the past year. Over the past 52 weeks it has traded between $81.60 and $105.26.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Church & Dwight Company, Inc.'s investor relations page. Walnut is informational, not investment advice.
What does Church & Dwight Company, Inc. (CHD) do?
Church & Dwight is an American consumer packaged goods company headquartered in Ewing, New Jersey, that makes household, personal-care and specialty products. It sells more than 80 brands, but roughly a dozen "power brands" (Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel, Batiste, Waterpik, TheraBreath, Hero Cosmetics and others) drive the bulk of revenue. The mix blends slow-and-steady staples like baking soda and laundry additives with faster-growing personal-care acquisitions, and the company has a long track record of bolt-on M&A and consistent dividend increases.
The investment picture is that of a defensive compounder. CHD posts modest but reliable organic growth, expanding gross margins from productivity programs, and strong free cash flow, which supports buybacks and a multi-decade dividend history. The tension is valuation: the stock trades around 30x earnings, a premium to the household-products group, at a time when U.S. organic growth has been soft and the 2026 plan leans on new-product launches and back-half execution. Bulls point to margin gains and the personal-care pivot, while skeptics see a stretched multiple against muted domestic demand and heavy competition from far larger rivals.
What's driving Church & Dwight Company, Inc. (CHD)?
1. Power-brand and personal-care mix
A concentrated set of power brands (Arm & Hammer, OxiClean, Trojan, Batiste, TheraBreath, Waterpik, Hero Cosmetics) generates most of the revenue, and the faster-growing personal-care names give CHD a higher-growth tilt than a pure household-products company. Continued innovation, notably around TheraBreath toothpaste, is central to the 2026 growth story.
2. Margin expansion and productivity
Adjusted gross margin expanded about 130 basis points to roughly 46.4% in Q1 2026 as productivity programs, acquisitions and favorable FX more than offset inflation and tariff costs. Sustained gross-margin gains are a key lever for the 5% to 8% adjusted EPS growth the company targets for 2026.
3. Cash generation and shareholder returns
CHD guides to roughly $1.15 billion of free cash flow in 2026, funding a long-running dividend (a dividend aristocrat with decades of increases) plus buybacks and bolt-on acquisitions. The forward dividend is about $1.23 per share for a yield near 1.3%.
4. Bolt-on M&A engine
Acquisitions like Waterpik, TheraBreath, Hero Cosmetics and Touchland have historically refreshed the portfolio toward higher-growth categories. Continued disciplined dealmaking is part of how management aims to offset slower legacy-brand growth.
What are the risks to Church & Dwight Company, Inc. (CHD)?
U.S. organic growth has been soft, with some domestic categories declining, so 2026 guidance is back-half weighted and carries execution risk on new-product launches. At around 30x trailing earnings, the valuation is a premium to the household-products group and leaves little margin for error if volumes or margins disappoint. The company competes with far larger rivals such as Procter & Gamble and Colgate-Palmolive that have bigger marketing budgets and shelf presence. Input-cost inflation, tariffs and private-label competition can pressure margins, and CHD faces routine product-related consumer litigation typical of large CPG companies. A separate SEC proxy-disclosure matter involving a former CEO was settled in 2024 and is not an active securities-fraud case.
How is Church & Dwight Company, Inc. (CHD) valued? (approximate, July 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Church & Dwight Company, Inc.'s investor relations page or your broker.
- Revenue (TTM): ~$6.2B
- Market cap: ~$23B
- P/E (TTM): ~32x
- EPS (TTM): ~$3.04
- Dividend yield: ~1.3%
- 2026 FCF guide: ~$1.15B
Q1 2026 net sales were about $1.47 billion (up 0.2%), with organic sales up 5.0% and adjusted EPS of $0.95, both ahead of the company outlook. Management targets roughly 3% to 4% organic growth and 5% to 8% adjusted EPS growth for 2026. The premium multiple reflects CHD's defensive profile and margin expansion, but it also assumes steady execution against soft domestic demand.
Who competes with Church & Dwight Company, Inc. (CHD)?
Household-products giants
Procter & Gamble and Colgate-Palmolive dominate laundry, oral care and household categories with far larger marketing budgets and shelf presence, making it harder for CHD's newer SKUs to gain sustained traction.
Diversified consumer staples
Unilever, Reckitt, Clorox and Henkel overlap across cleaning, personal care and specialty products, competing for the same shelf space and price points where CHD's value-oriented brands play.
Private label and niche personal care
Retailer private-label products pressure legacy value brands on price, while focused personal-care and beauty upstarts compete with CHD's acquired growth brands like Batiste, Hero Cosmetics and TheraBreath.
How to invest in Church & Dwight Company, Inc. (CHD)
There are three common ways to get CHD exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so CHD sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where CHD fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Church & Dwight Company, Inc. (CHD)
CHD is a well-run, defensive staples name valued at a premium, so the debate is about paying up for consistency versus the drag from soft U.S. organic growth.
More on Church & Dwight Company, Inc. (CHD)
Whether CHD is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CHD a buy?, and where the stock could go from here in the CHD stock forecast.
For income investors, whether CHD pays a dividend and how the payout looks is covered in does CHD pay a dividend?
Build a basket around CHD with Walnut
Use Church & Dwight Company, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What does Church & Dwight do?
+
It is a consumer packaged goods company that makes household, personal-care and specialty products. Its best-known brands include Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel, Batiste, Waterpik and TheraBreath.
Is CHD a dividend stock?
+
Yes. Church & Dwight has a decades-long record of paying and raising its dividend, making it a dividend aristocrat. The forward dividend is around $1.23 per share, a yield near 1.3%, paid quarterly.
Why does CHD trade at a high P/E?
+
The stock carries a premium multiple (around 30x earnings) because investors value its defensive staples profile, consistent free cash flow, margin expansion and long dividend history. That premium also assumes steady execution.
What are Church & Dwight's power brands?
+
Although CHD sells more than 80 brands, roughly a dozen power brands generate most of the revenue, including Arm & Hammer, OxiClean, Trojan, Nair, First Response, Orajel and Batiste, plus acquired growth brands like Waterpik, TheraBreath and Hero Cosmetics.
How did CHD perform in early 2026?
+
First-quarter 2026 net sales were about $1.47 billion, up 0.2%, with organic sales up 5.0% and adjusted EPS of $0.95. Both revenue and earnings came in ahead of the company's own outlook.
Who are Church & Dwight's main competitors?
+
Its largest rivals are household-products giants Procter & Gamble and Colgate-Palmolive, along with diversified staples companies like Unilever, Reckitt and Clorox, plus private-label products and niche personal-care brands.
What are the biggest risks for CHD?
+
Soft U.S. organic growth, a premium valuation with little room for error, competition from larger rivals, input-cost inflation and tariffs, and back-half-weighted 2026 guidance that depends on new-product execution.
Is there a securities-fraud case against Church & Dwight?
+
No active securities-fraud class action is on record. An SEC proxy-disclosure matter involving a former CEO was settled in 2024, and the company faces routine product-related consumer litigation typical of large consumer goods firms. Walnut is not an investment adviser.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Church & Dwight Company, Inc.'s investor relations page or your broker before making investment decisions.